Acute myeloid leukemia (AML) with erythroid predominance exhibits clinical and molecular characteristics that differ from other types of AML

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Zuo, Zhuang ^a   Medeiros, L Jeffrey ^a   Chen, Zhao ^a   Liu, Dingsheng ^a,b   Bueso Ramos, Carlos E ^a   Luthra, Rajyalakshmi ^a   Wang, Sa A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLT3 LIGAND; NUCLEOPHOSMIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CODON; CONTROLLED STUDY; ERYTHROID CELL; EXON; FEMALE; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; MYELODYSPLASTIC SYNDROME; MYOBLAST; NONHUMAN; ONCOGENE K RAS; ONCOGENE N RAS; OVERALL SURVIVAL; POINT MUTATION; PROTEIN DOMAIN; PYROSEQUENCING; REFRACTORY ANEMIA WITH EXCESS BLASTS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMPUTATIONAL BIOLOGY; CYTOGENETIC ANALYSIS; ERYTHROID PRECURSOR CELLS; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84864219624     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041485     Document Type: Article

References (27)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, et al. (1985) Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 103: 620-625.
2. Di Guglielmo G, (1917) Richerche di ematologia. I. Un caso di eritroleucemia. Megacariociti in circolo e loro funzione piastrinopoietico. Folia Medica (Pavia) 13: 386.
3. Galton DAG DJ, Peto R, (1975) The relationship between morphology and other features of acute myeloid leukaemia and their prognostic significance. Report on the Medical Research Council's Working Party on Leukaemia in Adults. Br J Haematol 31.
4. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, et al. (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114: 937-951.
5. Bacher U, Haferlach C, Alpermann T, Kern W, Schnittger S, et al. (2011) Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells. Haematologica 96: 1284-1292.
6. Santos FP, Bueso-Ramos CE, Ravandi F, (2010) Acute erythroleukemia: diagnosis and management. Expert Rev Hematol 3: 705-718.
7. Hasserjian RP, Zuo Z, Garcia C, Tang G, Kasyan A, et al. (2010) Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification. Blood 115: 1985-1992.
8. Wang SA, Tang G, Fadare O, Hao S, Raza A, et al. (2008) Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification. Mod Pathol 21: 1394-1402.
9. Kasyan A, Medeiros LJ, Zuo Z, Santos FP, Ravandi-Kashani F, et al. (2010) Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous disease. Mod Pathol 23: 1113-1126.
10. Zuo Z, Polski JM, Kasyan A, Medeiros LJ, (2010) Acute erythroid leukemia. Arch Pathol Lab Med 134: 1261-1270.
11. Bains A, Luthra R, Medeiros LJ, Zuo Z, (2011) FLT3 and NPM1 Mutations in Myelodysplastic Syndromes: Frequency and Potential Value for Predicting Progression to Acute Myeloid Leukemia. Am J Clin Pathol 135: 62-69.
12. Lin P, Jones D, Medeiros LJ, Chen W, Vega-Vazquez F, et al. (2006) Activating FLT3 mutations are detectable in chronic and blast phase of chronic myeloproliferative disorders other than chronic myeloid leukemia. Am J Clin Pathol 126: 530-533.
13. Zuo Z, Chen SS, Chandra PK, Galbincea JM, Soape M, et al. (2009) Application of COLD-PCR for improved detection of KRAS mutations in clinical samples. Mod Pathol 22: 1023-1031.
14. Grimwade D, Hills RK, Moorman AV, Walker H, Chatters S, et al. (2010) Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 116: 354-365.
15. Schnittger S, Schoch C, Kern W, Mecucci C, Tschulik C, et al. (2005) Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype. Blood 106: 3733-3739.
16. Thiede C, Koch S, Creutzig E, Steudel C, Illmer T, et al. (2006) Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood 107: 4011-4020.
17. Santos FP, Faderl S, Garcia-Manero G, Koller C, Beran M, et al. (2009) Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution. Leukemia 23: 2275-2280.
18. Suzuki T, Kiyoi H, Ozeki K, Tomita A, Yamaji S, et al. (2005) Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia. Blood 106: 2854-2861.
19. Dohner K, Schlenk RF, Habdank M, Scholl C, Rucker FG, et al. (2005) Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations. Blood 106: 3740-3746.
20. Ruan GR, Li JL, Qin YZ, Li LD, Xie M, et al. (2009) Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia. Ann Hematol 88: 159-166.
21. Frohling S, Lipka DB, Kayser S, Scholl C, Schlenk RF, et al. (2006) Rare occurrence of the JAK2 V617F mutation in AML subtypes M5, M6, and M7. Blood 107: 1242-1243.
22. Steensma DP, McClure RF, Karp JE, Tefferi A, Lasho TL, et al. (2006) JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained. Leukemia 20: 971-978.
23. Shimizu R, Engel JD, Yamamoto M, (2008) GATA1-related leukaemias. Nat Rev Cancer 8: 279-287.
24. Ebert BL, (2010) Genetic deletions in AML and MDS. Best Pract Res Clin Haematol 23: 457-461.
25. Hopfer O, Nolte F, Mossner M, Komor M, Kmetsch A, et al. (2012) Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis. Eur J Haematol 88: 144-153.
26. Olopade OI, Thangavelu M, Larson RA, Mick R, Kowal-Vern A, et al. (1992) Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia. Blood 80: 2873-2882.
27. Bacher U, Haferlach T, Kern W, Haferlach C, Schnittger S, (2007) A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia. Haematologica 92: 744-752.